Switch To Branded denied for missing prior authorization by Humana?

Humana's specific coverage criteria for switch to branded are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Humana Requires Prior Authorization for the Branded Drug — and How to Navigate the Process

Prior authorization (PA) for a branded drug when a generic equivalent exists is standard practice at Humana. The plan requires your prescriber to submit clinical documentation before it will approve coverage, typically to confirm that the generic or other formulary alternatives are not clinically appropriate. A "prior-auth-required" denial means the prescription was dispensed or billed without an approved PA on file — or the submitted PA was incomplete and denied.

## Why This Denial Is Appealable

If a PA was submitted and denied on clinical grounds, that denial is a reviewable adverse benefit determination subject to the same appeal rights as any other medical-necessity denial. If no PA was submitted (or the prescription was filled before approval), there may still be a retrospective review option — ask Humana within the appeal window.

Your federal appeal rights: - Internal appeal (ACA §2719 / ERISA §503): File within 180 days of the denial. The plan must provide the specific clinical criteria it applied and the basis for denial. - External review: After exhausting internal appeal, an IRO decides independently. The window is generally up to four months from final internal denial. - Expedited review (72 hours): Available when the standard timeline would seriously jeopardize your health — relevant for ongoing conditions requiring uninterrupted therapy.

## What to Gather

• Copy of the PA determination and denial reason: The specific finding (missing documentation, failed clinical criteria, etc.) drives your response.
• Humana's PA criteria for this drug: Request the current prior-authorization criteria document. Map your documentation to every listed requirement.
• Clinical documentation of why the branded version is needed: Adverse reaction or failure on the generic, specific formulation requirement, or other objective clinical basis.
• Prescriber PA appeal letter: Should address each denial reason directly, citing chart notes and objective findings — not just restating the original request.
• Treatment history: Dates, outcomes, and adverse events on formulary alternatives.

## Criteria-Mapping Structure

| Humana PA Criterion | Supporting Documentation | |---|---| | Confirmed diagnosis | Diagnosis from chart, specialist note | | Formulary alternative tried | Dates, dose range, and documented outcome | | Clinical reason for branded version | Prescriber letter with objective chart evidence | | [Additional PA criterion] | Corresponding chart note or lab result |

Your appeal letter should open by identifying the PA denial reason, then answer each criterion with specific chart documentation. If the PA was denied for missing information, submit the information along with a cover letter. If denied on clinical grounds, build a full medical-necessity argument. Expedited review is available immediately if your health cannot tolerate a multi-week delay.